[1]刘金虹.阿奇霉素用于儿科抗感染的不良反应分析[J].医学信息,2020,33(16):161-162.[doi:10.3969/j.issn.1006-1959.2020.16.052]
　LIU Jin-hong.Analysis of Adverse Reaction of Azithromycin in Pediatric Anti-infection[J].Medical Information,2020,33(16):161-162.[doi:10.3969/j.issn.1006-1959.2020.16.052]
点击复制

阿奇霉素用于儿科抗感染的不良反应分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年16期
页码:
161-162
栏目:
药物与临床
出版日期:
2020-08-15

文章信息/Info

Title:
Analysis of Adverse Reaction of Azithromycin in Pediatric Anti-infection
文章编号:
1006-1959（2020）16-0161-02
作者:
刘金虹
（天津市宝坻区人民医院/天津医科大学宝坻临床学院药剂科，天津 301800）
Author(s):
LIU Jin-hong
(Tianjin Baodi District People’s Hospital/Department of Pharmacy,Tianjin Medical University Baodi Clinical College,Tianjin 301800,China)
关键词:
阿奇霉素; 给药途径; 抗感染; 不良反应; 危险因素
Keywords:
Azithromycin; Route of administration; Anti-infection; Adverse reactions; Risk factors
分类号:
R978.1
DOI:
10.3969/j.issn.1006-1959.2020.16.052
文献标志码:
A
摘要:
目的 分析阿奇霉素在儿科抗感染中发生不良反应的危险因素。方法 选择2018年5月~2019年5月在我院诊治采用阿奇霉素治疗的96例患儿为研究对象，比较不同给药途径不良反应发生率，分析患儿年龄、体质量、用药频率是否合理、适应症选择是否合理、用药剂量是否合理、给药浓度是否合理及疗程对发生不良反应的影响。结果 口服阿奇霉素患儿不良反应发生率为10.86%，低于静脉注射阿奇霉素的20.00%，差异有统计学意义（P＜0.05）；不良反应组与未发生不良反应组年龄、体质量、用药频率、适应证选择、用药剂量、给药浓度、治疗疗程比较，差异有统计学意义（P＜0.05）； Logistic回归分析显示，用药剂量、给药浓度、用药频率、适应证选择不合理为不良反应发生独立危险因素（P＜0.05）。结论 在儿科抗感染治疗中阿奇霉素应尽量选择口服给药方式，严格控制给药剂量、浓度及适应证，并尽量缩短用药疗程，以降低阿奇霉素不良反应的发生率。
Abstract:
Objective To analyze the risk factors of adverse reactions of azithromycin in pediatric anti-infection.Methods 96 children who were treated with azithromycin in our hospital from May 2018 to May 2019 were selected as the research objects. The incidence of adverse reactions of different administration routes was compared, and the age, weight, and frequency of medication of the children were analyzed whether they were reasonable. Whether the selection of indications is reasonable, whether the dosage of the drug is reasonable, whether the concentration of the drug is reasonable, and the influence of the course of treatment on the occurrence of adverse reactions.Results The incidence of adverse reactions in children with oral azithromycin was 10.86%, which was lower than 20.00% of intravenous azithromycin,the difference was statistically significant (P＜0.05). The adverse reaction group and the non-adverse reaction group had age, body weight, frequency of medication,comparison of indication selection, dosage, concentration, treatment course, the difference was statistically significant (P＜0.05); Logistic regression analysis showed that unreasonable selection of dosage, concentration, frequency, and indications was the occurrence of adverse reactions independent risk factors (P＜0.05).Conclusion In pediatric anti-infective therapy, azithromycin should be administered by oral administration, the dosage, concentration and indications should be strictly controlled, and the course of treatment should be shortened as much as possible to reduce the incidence of azithromycin adverse reactions.

参考文献/References:

[1]张静,石祥奎.儿科应用注射用乳糖酸阿奇霉素不良反应61例分析[J].淮海医药,2016,34(1):97-99.[2]赵雁雄,施苏林,刘姗姗.口服阿奇霉素、口服及静脉红霉素治疗呼吸道支原体感染患儿的临床效果及不良反应对比[J].中国生化药物杂志,2017,37(4):376-378.[3]吕清.阿奇霉素不同给药方式治疗小儿肺炎支原体感染相关性支气管炎的效果对比及对患者满意度的影响[J].中国农村卫生,2019,11(6):80.[4]焦伟杰,高天曙,陈团营.注射用阿奇霉素致儿童不良反应危险因素分析[J].中国药房,2016,27(24):3340-3342.[5]王素霞,王静,任常军,等.阿奇霉素序贯疗法治疗小儿支原体肺炎的疗效和安全性分析[J].中国生化药物杂志,2014,30(5):133-134,138.

相似文献/References:

[1]赵俊芝,赵永强,梁 曼.甲泼尼龙联合阿奇霉素治疗难治性支原体肺炎患儿的 临床效果分析[J].医学信息,2018,31(07):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
　ZHAO Jun-zhi,ZHAO Yong-qiang,LIANG Man.Analysis of the Clinical Effect of Methylprednisolone Combined with Azithromycin in Treatment of Children with Refractory Mycoplasma Pneumonia[J].Medical Information,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
[2]冯瑞丰.阿奇霉素治疗急性细菌性下呼吸道感染的 有效性和安全性评价[J].医学信息,2019,32(11):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
　FENG Rui-feng.Evaluation of the Efficacy and Safety of Azithromycin in the Treatment of Acute Bacterial Lower Respiratory Tract Infections[J].Medical Information,2019,32(16):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
[3]陈艳丽.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性的Meta分析[J].医学信息,2020,33(06):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
　CHEN Yan-li.Meta-analysis of the Efficacy and Safety of Methylprednisolone Combined with Azithromycin in the Treatment of Refractory Mycoplasmal Pneumonia in Children[J].Medical Information,2020,33(16):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
[4]张舒扬.阿奇霉素联合头孢地嗪对急性细菌性痢疾患儿白细胞计数及C-反应蛋白水平的影响[J].医学信息,2022,35(06):165.[doi:10.3969/j.issn.1006-1959.2022.06.043]
　ZHANG Shu-yang.Effect of Azithromycin Combined with Cefodizime on White Blood Cell Count and C-reactive Protein Level in Children with Acute Bacillary Dysentery[J].Medical Information,2022,35(16):165.[doi:10.3969/j.issn.1006-1959.2022.06.043]
[5]吴建伟.阿奇霉素联合头孢类药物在慢性阻塞性肺疾病急性加重期抗感染治疗中的疗效[J].医学信息,2022,35(13):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
　WU Jian-wei.Effect of Azithromycin Combined with Cephalosporins in Anti-infection Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2022,35(16):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
[6]温 鑫,邓 春.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效评价[J].医学信息,2023,36(06):147.[doi:10.3969/j.issn.1006-1959.2023.06.032]
　WEN Xin,DENG Chun.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Medical Information,2023,36(16):147.[doi:10.3969/j.issn.1006-1959.2023.06.032]
[7]郭志丽,刘改莲,贺 蓉.阿奇霉素、氨溴特罗联合肺力咳合剂对支原体感染患儿血常规及CRP水平的影响[J].医学信息,2023,36(09):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
　GUO Zhi-li,LIU Gai-lian,HE Rong.Effect of Azithromycin, Ambroxol Combined with Feilike Mixture on Blood Routine and CRP Level in Children with Mycoplasma Infection[J].Medical Information,2023,36(16):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
[8]皮祖骞.连花清瘟颗粒联合阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效[J].医学信息,2023,36(10):154.[doi:10.3969/j.issn.1006-1959.2023.10.034]
　PI Zu-qian.Clinical Effect of Lianhua Qingwen Granules Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Medical Information,2023,36(16):154.[doi:10.3969/j.issn.1006-1959.2023.10.034]
[9]章云云.美洛西林联合阿奇霉素治疗小儿肺炎链球菌肺炎的临床效果[J].医学信息,2023,36(13):131.[doi:10.3969/j.issn.1006-1959.2023.13.027]
　ZHANG Yun-yun.Clinical Effect of Mezlocillin Combined with Azithromycin in the Treatment of Children with Streptococcus Pneumoniae Pneumonia[J].Medical Information,2023,36(16):131.[doi:10.3969/j.issn.1006-1959.2023.13.027]
[10]杨芬香.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎、支气管炎的疗效评价[J].医学信息,2023,36(13):144.[doi:10.3969/j.issn.1006-1959.2023.13.031]
　YANG Fen-xiang.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Pneumonia and Bronchitis in Children[J].Medical Information,2023,36(16):144.[doi:10.3969/j.issn.1006-1959.2023.13.031]

更新日期/Last Update: 1900-01-01